ID MYO4_YEAST Reviewed; 1471 AA. AC P32492; D6VPI9; DT 01-OCT-1993, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-1993, sequence version 1. DT 02-SEP-2026, entry version 208. DE RecName: Full=Myosin-4; DE AltName: Full=SWI5-dependent HO expression protein 1; GN Name=MYO4; Synonyms=SHE1; OrderedLocusNames=YAL029C; ORFNames=FUN22; OS Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast). OC Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes; OC Saccharomycetales; Saccharomycetaceae; Saccharomyces. OX NCBI_TaxID=559292; RN [1] RP NUCLEOTIDE SEQUENCE. RX PubMed=8056830; DOI=10.1242/jcs.107.4.1055; RA Haarer B.K., Petzold A., Lillie S.H., Brown S.S.; RT "Identification of MYO4, a second class V myosin gene in yeast."; RL J. Cell Sci. 107:1055-1064(1994). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC 204508 / S288c; RX PubMed=7731988; DOI=10.1073/pnas.92.9.3809; RA Bussey H., Kaback D.B., Zhong W.-W., Vo D.H., Clark M.W., Fortin N., RA Hall J., Ouellette B.F.F., Keng T., Barton A.B., Su Y., Davies C.J., RA Storms R.K.; RT "The nucleotide sequence of chromosome I from Saccharomyces cerevisiae."; RL Proc. Natl. Acad. Sci. U.S.A. 92:3809-3813(1995). RN [3] RP GENOME REANNOTATION. RC STRAIN=ATCC 204508 / S288c; RX PubMed=24374639; DOI=10.1534/g3.113.008995; RA Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R., RA Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S., RA Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.; RT "The reference genome sequence of Saccharomyces cerevisiae: Then and now."; RL G3 (Bethesda) 4:389-398(2014). RN [4] RP FUNCTION. RX PubMed=10212145; DOI=10.1242/jcs.112.10.1511; RA Munchow S., Sauter C., Jansen R.P.; RT "Association of the class V myosin Myo4p with a localised messenger RNA in RT budding yeast depends on She proteins."; RL J. Cell Sci. 112:1511-1518(1999). RN [5] RP FUNCTION, AND INTERACTION WITH SHE2 AND SHE3. RX PubMed=11032818; DOI=10.1093/emboj/19.20.5514; RA Bohl F., Kruse C., Frank A., Ferring D., Jansen R.P.; RT "She2p, a novel RNA-binding protein tethers ASH1 mRNA to the Myo4p myosin RT motor via She3p."; RL EMBO J. 19:5514-5524(2000). RN [6] RP FUNCTION, AND INTERACTION WITH SHE3. RX PubMed=11101531; DOI=10.1093/emboj/19.23.6592; RA Long R.M., Gu W., Lorimer E., Singer R.H., Chartrand P.; RT "She2p is a novel RNA-binding protein that recruits the Myo4p-She3p complex RT to ASH1 mRNA."; RL EMBO J. 19:6592-6601(2000). RN [7] RP INTERACTION WITH SHE2 AND SHE3. RX PubMed=10792032; DOI=10.1073/pnas.080585897; RA Takizawa P.A., Vale R.D.; RT "The myosin motor, Myo4p, binds Ash1 mRNA via the adapter protein, She3p."; RL Proc. Natl. Acad. Sci. U.S.A. 97:5273-5278(2000). RN [8] RP FUNCTION, AND SUBCELLULAR LOCATION. RX PubMed=12499354; DOI=10.1083/jcb.200207101; RA Kruse C., Jaedicke A., Beaudouin J., Bohl F., Ferring D., Guttler T., RA Ellenberg J., Jansen R.P.; RT "Ribonucleoprotein-dependent localization of the yeast class V myosin RT Myo4p."; RL J. Cell Biol. 159:971-982(2002). RN [9] RP LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS]. RX PubMed=14562106; DOI=10.1038/nature02046; RA Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N., RA O'Shea E.K., Weissman J.S.; RT "Global analysis of protein expression in yeast."; RL Nature 425:737-741(2003). RN [10] RP FUNCTION. RX PubMed=15328357; DOI=10.1074/jbc.m406086200; RA Gonsalvez G.B., Little J.L., Long R.M.; RT "ASH1 mRNA anchoring requires reorganization of the Myo4p-She3p-She2p RT transport complex."; RL J. Biol. Chem. 279:46286-46294(2004). RN [11] RP FUNCTION, AND DISRUPTION PHENOTYPE. RX PubMed=15082763; DOI=10.1128/mcb.24.9.3670-3681.2004; RA Tadauchi T., Inada T., Matsumoto K., Irie K.; RT "Posttranscriptional regulation of HO expression by the Mkt1-Pbp1 RT complex."; RL Mol. Cell. Biol. 24:3670-3681(2004). RN [12] RP X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1091-1471, FUNCTION, AND RP INTERACTION WITH SHE3. RX PubMed=20439999; DOI=10.1083/jcb.201002076; RA Heuck A., Fetka I., Brewer D.N., Huls D., Munson M., Jansen R.P., RA Niessing D.; RT "The structure of the Myo4p globular tail and its function in ASH1 mRNA RT localization."; RL J. Cell Biol. 189:497-510(2010). CC -!- FUNCTION: Part of the mRNA localization machinery that restricts CC accumulation of certain proteins to the bud and in the daughter cell. CC Recruited to specific mRNAs including the ASH1 mRNA, coding for a CC repressor of the HO endonuclease, via its interaction with SHE3. CC {ECO:0000269|PubMed:10212145, ECO:0000269|PubMed:11032818, CC ECO:0000269|PubMed:11101531, ECO:0000269|PubMed:12499354, CC ECO:0000269|PubMed:15082763, ECO:0000269|PubMed:15328357, CC ECO:0000269|PubMed:20439999}. CC -!- SUBUNIT: Interacts with SHE2 and SHE3. {ECO:0000269|PubMed:10792032, CC ECO:0000269|PubMed:11032818, ECO:0000269|PubMed:11101531, CC ECO:0000269|PubMed:20439999}. CC -!- INTERACTION: CC P32492; P36068: SHE2; NbExp=4; IntAct=EBI-11681, EBI-26866; CC P32492; P38272: SHE3; NbExp=11; IntAct=EBI-11681, EBI-21600; CC P32492; P51534: SHE4; NbExp=4; IntAct=EBI-11681, EBI-17086; CC -!- SUBCELLULAR LOCATION: Bud {ECO:0000269|PubMed:12499354}. CC Note=Accumulates preferentially in growing buds. CC -!- DISRUPTION PHENOTYPE: Abnormal localization of ASH1 protein to daughter CC cell, with protein mislocalized to mother and daughter CC (PubMed:15082763). Decreases HO mRNA level (PubMed:15082763). CC {ECO:0000269|PubMed:15082763}. CC -!- MISCELLANEOUS: Present with 2210 molecules/cell in log phase SD medium. CC {ECO:0000269|PubMed:14562106}. CC -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase CC superfamily. Myosin family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M90057; AAC37409.1; -; Unassigned_DNA. DR EMBL; U12980; AAC05003.1; -; Genomic_DNA. DR EMBL; BK006935; DAA06959.1; -; Genomic_DNA. DR PIR; S30790; S30790. DR RefSeq; NP_009373.1; NM_001178174.1. DR PDB; 3MMI; X-ray; 2.30 A; A/B=1091-1471. DR PDB; 4LL6; X-ray; 2.30 A; A=1098-1471. DR PDB; 4LL8; X-ray; 3.58 A; A=918-1471. DR AlphaFoldDB; P32492; -. DR SMR; P32492; -. DR BioGRID; 31737; 140. DR ComplexPortal; CPX-1501; Myosin class V complex, MYO4 variant. DR DIP; DIP-5761N; -. DR FunCoup; P32492; 491. DR IntAct; P32492; 35. DR MINT; P32492; -. DR STRING; 4932.YAL029C; -. DR iPTMnet; P32492; -. DR PaxDb; 4932-YAL029C; -. DR PeptideAtlas; P32492; -. DR EnsemblFungi; YAL029C_mRNA; YAL029C; YAL029C. DR GeneID; 851204; -. DR KEGG; sce:YAL029C; -. DR AGR; SGD:S000000027; -. DR SGD; S000000027; MYO4. DR VEuPathDB; FungiDB:YAL029C; -. DR eggNOG; KOG0160; Eukaryota. DR HOGENOM; CLU_000192_9_0_1; -. DR InParanoid; P32492; -. DR OMA; DESWASK; -. DR OrthoDB; 6108017at2759; -. DR BioCyc; YEAST:G3O-28840-MONOMER; -. DR Reactome; R-SCE-190873; Gap junction degradation. DR Reactome; R-SCE-9013419; RHOT2 GTPase cycle. DR Reactome; R-SCE-9013420; RHOU GTPase cycle. DR Reactome; R-SCE-9013425; RHOT1 GTPase cycle. DR BioGRID-ORCS; 851204; 0 hits in 10 CRISPR screens. DR EvolutionaryTrace; P32492; -. DR PRO; PR:P32492; -. DR Proteomes; UP000002311; Chromosome I. DR RNAct; P32492; protein. DR GO; GO:0015629; C:actin cytoskeleton; IBA:GO_Central. DR GO; GO:0005933; C:cellular bud; IDA:SGD. DR GO; GO:0005934; C:cellular bud tip; IDA:SGD. DR GO; GO:0031941; C:filamentous actin; IDA:SGD. DR GO; GO:0005739; C:mitochondrion; HDA:SGD. DR GO; GO:0031475; C:myosin V complex; NAS:ComplexPortal. DR GO; GO:0051015; F:actin filament binding; IDA:SGD. DR GO; GO:0005524; F:ATP binding; IEA:InterPro. DR GO; GO:0000146; F:microfilament motor activity; IDA:SGD. DR GO; GO:0006897; P:endocytosis; IBA:GO_Central. DR GO; GO:0048309; P:endoplasmic reticulum inheritance; IMP:SGD. DR GO; GO:0008298; P:intracellular mRNA localization; IMP:SGD. DR GO; GO:0007533; P:mating type switching; IMP:SGD. DR GO; GO:0030050; P:vesicle transport along actin filament; NAS:ComplexPortal. DR CDD; cd15479; fMyo4p_CBD; 1. DR CDD; cd01380; MYSc_Myo5; 1. DR FunFam; 1.20.58.530:FF:000002; Class V myosin; 1. DR FunFam; 1.10.10.820:FF:000001; Myosin heavy chain; 1. DR Gene3D; 1.10.10.820; -; 1. DR Gene3D; 1.20.5.190; -; 1. DR Gene3D; 1.20.5.4820; -; 1. DR Gene3D; 1.20.58.530; -; 1. DR Gene3D; 3.40.850.10; Kinesin motor domain; 1. DR Gene3D; 1.20.120.720; Myosin VI head, motor domain, U50 subdomain; 1. DR InterPro; IPR002710; Dilute_dom. DR InterPro; IPR000048; IQ_motif_EF-hand-BS. DR InterPro; IPR036961; Kinesin_motor_dom_sf. DR InterPro; IPR001609; Myosin_head_motor_dom-like. DR InterPro; IPR036103; MYSc_Myo5. DR InterPro; IPR027417; P-loop_NTPase. DR InterPro; IPR004009; SH3_Myosin. DR PANTHER; PTHR13140:SF706; DILUTE CLASS UNCONVENTIONAL MYOSIN, ISOFORM C; 1. DR PANTHER; PTHR13140; MYOSIN; 1. DR Pfam; PF01843; DIL; 1. DR Pfam; PF00612; IQ; 1. DR Pfam; PF00063; Myosin_head; 1. DR PRINTS; PR00193; MYOSINHEAVY. DR SMART; SM01132; DIL; 1. DR SMART; SM00015; IQ; 4. DR SMART; SM00242; MYSc; 1. DR SUPFAM; SSF50084; Myosin S1 fragment, N-terminal domain; 1. DR SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1. DR PROSITE; PS51126; DILUTE; 1. DR PROSITE; PS50096; IQ; 2. DR PROSITE; PS51456; MYOSIN_MOTOR; 1. DR PROSITE; PS51844; SH3_LIKE; 1. DR PDBsum; 3MMI; -. DR PDBsum; 4LL6; -. DR PDBsum; 4LL8; -. PE 1: Evidence at protein level; KW 3D-structure; Actin-binding; ATP-binding; Calmodulin-binding; Coiled coil; KW Motor protein; mRNA transport; Myosin; Nucleotide-binding; KW Reference proteome; Repeat; Transport. FT CHAIN 1..1471 FT /note="Myosin-4" FT /id="PRO_0000123491" FT DOMAIN 4..57 FT /note="Myosin N-terminal SH3-like" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01190" FT DOMAIN 71..777 FT /note="Myosin motor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00782" FT DOMAIN 781..801 FT /note="IQ 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00116" FT DOMAIN 804..824 FT /note="IQ 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00116" FT DOMAIN 829..849 FT /note="IQ 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00116" FT DOMAIN 876..898 FT /note="IQ 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00116" FT DOMAIN 899..928 FT /note="IQ 5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00116" FT DOMAIN 1164..1419 FT /note="Dilute" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00503" FT REGION 647..669 FT /note="Actin-binding" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00782" FT COILED 938..1063 FT BINDING 165..172 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255" FT HELIX 1104..1109 FT /evidence="ECO:0007829|PDB:3MMI" FT HELIX 1111..1116 FT /evidence="ECO:0007829|PDB:3MMI" FT HELIX 1117..1122 FT /evidence="ECO:0007829|PDB:3MMI" FT HELIX 1128..1130 FT /evidence="ECO:0007829|PDB:4LL6" FT HELIX 1138..1152 FT /evidence="ECO:0007829|PDB:3MMI" FT HELIX 1156..1176 FT /evidence="ECO:0007829|PDB:3MMI" FT TURN 1179..1181 FT /evidence="ECO:0007829|PDB:3MMI" FT HELIX 1182..1193 FT /evidence="ECO:0007829|PDB:3MMI" FT HELIX 1196..1204 FT /evidence="ECO:0007829|PDB:3MMI" FT HELIX 1205..1207 FT /evidence="ECO:0007829|PDB:4LL6" FT HELIX 1217..1253 FT /evidence="ECO:0007829|PDB:3MMI" FT HELIX 1255..1259 FT /evidence="ECO:0007829|PDB:3MMI" FT HELIX 1262..1264 FT /evidence="ECO:0007829|PDB:3MMI" FT STRAND 1265..1267 FT /evidence="ECO:0007829|PDB:3MMI" FT HELIX 1270..1289 FT /evidence="ECO:0007829|PDB:3MMI" FT HELIX 1294..1319 FT /evidence="ECO:0007829|PDB:3MMI" FT HELIX 1325..1342 FT /evidence="ECO:0007829|PDB:3MMI" FT TURN 1343..1345 FT /evidence="ECO:0007829|PDB:3MMI" FT HELIX 1350..1353 FT /evidence="ECO:0007829|PDB:3MMI" FT HELIX 1354..1364 FT /evidence="ECO:0007829|PDB:3MMI" FT HELIX 1370..1377 FT /evidence="ECO:0007829|PDB:3MMI" FT HELIX 1385..1393 FT /evidence="ECO:0007829|PDB:3MMI" FT STRAND 1398..1401 FT /evidence="ECO:0007829|PDB:4LL6" FT HELIX 1407..1423 FT /evidence="ECO:0007829|PDB:3MMI" FT HELIX 1440..1442 FT /evidence="ECO:0007829|PDB:3MMI" FT HELIX 1460..1467 FT /evidence="ECO:0007829|PDB:3MMI" SQ SEQUENCE 1471 AA; 169344 MW; E79C0FE72B041E95 CRC64; MSFEVGTKCW YPHKEQGWIG GEVTKNDFFE GTFHLELKLE DGETVSIETN SFENDDDHPT LPVLRNPPIL ESTDDLTTLS YLNEPAVLHA IKKRYMNGQI YTYSGIVLIA ANPFDKVDHL YSREMIQNYS SKRKDELEPH LFAIAEEAYR FMVHEKANQT VVVSGESGAG KTVSAKYIMR YFASVQESNN REGEVEMSQI ESQILATNPI MEAFGNAKTT RNDNSSRFGK YLQILFDENT TIRGSKIRTY LLEKSRLVYQ PETERNYHIF YQILEGLPEP VKQELHLSSP KDYHYTNQGG QPNIAGIDEA REYKITTDAL SLVGINHETQ LGIFKILAGL LHIGNIEMKM TRNDASLSSE EQNLQIACEL LGIDPFNFAK WIVKKQIVTR SEKIVTNLNY NQALIARDSV AKFIYSTLFD WLVDNINKTL YDPELDQQDH VFSFIGILDI YGFEHFEKNS FEQFCINYAN EKLQQEFNQH VFKLEQEEYV KEEIEWSFIE FSDNQPCIDL IENKLGILSL LDEESRLPSG SDESWASKLY SAFNKPPSNE VFSKPRFGQT KFIVSHYAVD VEYEVEGFIE KNRDSVSLGH LDVFKATTNP IFKQILDNRE LRSDDAPEEQ NTEKKIMIPA RLSQKKPTLG SMFKKSLGEL MAIINSTNVH YIRCIKPNSE KKPWEFDNLM VLSQLRACGV LETIRISCAG FPSRWTFDEF VQRYFLLTDY SLWSGILYNP DLPKEAIVNF CQSILDATIS DSAKYQIGNT KIFFKAGMLA FLEKLRTNKM NEICIIIQKK IRARYYRLQY LQTMESIKKC QSQIRSLLVR TRVDHELKTR AAILLQTNIR ALWKREYYRA AIGQIIKLQC TCKRKLILDS VNRKFMLMAA VIIQSYIRSY GHKTDYRTLK RSSILVQSAM RMQLARRRYI VLQKEVEERN IRASYGIGLL EEAIEFKNSF ILNLEMLNDS YTRLTQLLQG DLSNIPSKQR QEYETIVNGY NDKISKLKTL QVEIMNTLNK KNALKERKKK QSSLIQSHMQ SLAAIKGNKP SRLSDEVKSM KQELAFIENV IAQDFTTTYS ANKNDKVKGL GIAGQQVKPK LVNVIRRESG NPDLLELLMD LNCYTLEVTE GYLKKVNVTE VNGDNVLGPI HVITTVVSSL VRNGLLIQSS KFISKVLLTV ESIVMSLPKD ETMLGGIFWL SNLSRLPAFA ANQKTLYEAN GGDEKDKLTL IYLNDLENET LKVFDKIYST WLVKFMKHAS AHIEIFDMVL NEKLFKNSGD EKFAKLFTFL NEFDAVLCKF QVVDSMHTKI FNDTLKYLNV MLFNDLITKC PALNWKYGYE VDRNIERLVS WFEPRIEDVR PNLIQIIQAV KILQLKISNL NEFKLLFDFW YALNPAQIQA ILLKYKPANK GEAGVPNEIL NYLANVIKRE NLSLPGKMEI MLSAQFDSAK NHLRYDTSAI TQNSNTEGLA TVSKIIKLDR K //